Caption Management, LLC Cue Biopharma, Inc. Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.23 - $4.69 $31,220 - $65,660	14,000 New	14,000 $32,000
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $295,392 - $485,520	-27,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $296,480 - $395,216	27,200 New	27,200 $316,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.